Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA Healthcare raises 2025 guidance after Q3 diluted EPS rises 42.6% to $6.96

Positive Impact 4 of 5 guidance Written later

HCA Healthcare reported third-quarter 2025 revenue of $19.161 billion, up 9.6%, and net income attributable to HCA of $1.643 billion, or $6.96 per diluted share, compared with $4.88 a year earlier. The company raised its 2025 diluted EPS guidance to $27.00 to $28.00 per share, from $25.50 to $27.00, and declared a $0.72 quarterly dividend.

Key points

  • Q3 2025 revenue was $19.161 billion, up from $17.487 billion; diluted EPS was $6.96 versus $4.88.
  • Revised 2025 diluted EPS guidance is $27.00 to $28.00, up from $25.50 to $27.00 set on July 25, 2025.
  • Revised 2025 Adjusted EBITDA guidance is $15.250 billion to $15.650 billion, up from $14.700 billion to $15.300 billion.
  • Quarterly dividend of $0.72 per share is payable December 29, 2025, to holders of record on December 15, 2025.

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECOct 24, 2025, 7:16 AM ET
Accession number0001193125-25-249345

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.